COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 190 filers reported holding COHERUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,033,078 | +45.6% | 276,224 | +66.2% | 0.52% | +55.4% |
| Q2 2023 | $709,572 | -37.5% | 166,176 | +0.1% | 0.34% | -41.1% |
| Q1 2023 | $1,136,028 | +85962.7% | 166,086 | -0.4% | 0.57% | -15.8% |
| Q4 2022 | $1,320 | -99.9% | 166,722 | -0.7% | 0.68% | -23.5% |
| Q3 2022 | $1,613,000 | +37.4% | 167,867 | +3.5% | 0.88% | +42.5% |
| Q2 2022 | $1,174,000 | -44.0% | 162,146 | -0.2% | 0.62% | -36.6% |
| Q1 2022 | $2,097,000 | -19.5% | 162,432 | -0.5% | 0.98% | -8.8% |
| Q4 2021 | $2,605,000 | -0.7% | 163,198 | -0.0% | 1.07% | -9.7% |
| Q3 2021 | $2,623,000 | +19.7% | 163,210 | +3.0% | 1.19% | +59.3% |
| Q2 2021 | $2,191,000 | -8.6% | 158,427 | -3.4% | 0.75% | -5.9% |
| Q1 2021 | $2,396,000 | +17.1% | 164,029 | +39.3% | 0.79% | +2.3% |
| Q4 2020 | $2,046,000 | -6.2% | 117,731 | -1.0% | 0.78% | -25.5% |
| Q3 2020 | $2,182,000 | – | 118,955 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |